Following a broad domestic and international search, with the assistance of our Clairfield partners, DZG Investments, the Australian subsidiary of the Goubuli Group, a Chinese food and beverage company, has acquired an 80% stake in BJP Laboratories, a leading Australian contract manufacturer of listed medicines.
InterFinancial assumed a lead advisory role on the transaction and managed the transaction to completion.
“Thank you to an amazing team. Esti and I enjoyed the journey. We are certainly looking forward to a great future with our new partners.”
– Brian Siebert (co-owner BJP)